39211-56-8 Usage
Uses
Used in Pharmaceutical Industry:
2-(DIFLUOROMETHOXY)-4-METHYLANILINE serves as an intermediate in the synthesis of pharmaceuticals, contributing to the development of new medications due to its unique chemical structure and reactivity.
Used in Agrochemical Industry:
In the agrochemical sector, 2-(DIFLUOROMETHOXY)-4-METHYLANILINE is utilized as an intermediate, playing a role in the creation of compounds that help protect crops and enhance agricultural productivity.
Used in Dye Industry:
2-(DIFLUOROMETHOXY)-4-METHYLANILINE is also used in the dye industry, where it acts as an intermediate in the production of various dyes, contributing to the coloration and quality of textiles and other materials.
Used in Organic Compounds Production:
2-(DIFLUOROMETHOXY)-4-METHYLANILINE is employed in the synthesis of organic compounds, functioning as a building block for more complex molecules, which can have a range of applications across different industries.
Used in Medicinal Chemistry:
With its potential application in medicinal chemistry, 2-(DIFLUOROMETHOXY)-4-METHYLANILINE is used as a reagent in organic synthesis, aiding in the development of new chemical entities with therapeutic potential.
Used in Organic Synthesis:
As a reagent in organic synthesis, 2-(DIFLUOROMETHOXY)-4-METHYLANILINE is instrumental in the preparation of a variety of chemical products, showcasing its broad utility in the field of chemistry.
It is crucial to handle 2-(DIFLUOROMETHOXY)-4-METHYLANILINE with care due to its potential health and environmental hazards if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 39211-56-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,2,1 and 1 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 39211-56:
(7*3)+(6*9)+(5*2)+(4*1)+(3*1)+(2*5)+(1*6)=108
108 % 10 = 8
So 39211-56-8 is a valid CAS Registry Number.
39211-56-8Relevant academic research and scientific papers
IMIDAZO [4, 5 -C] PYRIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
-
Paragraph 0012, (2013/08/28)
Novel imidazolopyridines according to Formula I, able to inhibit JAK are disclosed, wherein R1 and Cy are as disclosed herein. These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic or inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
